SEARCH

SEARCH BY CITATION

References

  • 1
    Busuttil RW, Lake JR. Role of tacrolimus in the evolution of liver transplantation. Transplantation 2004; 77: S44.
  • 2
    Burroughs AK, Sabin CA, Rolles K, et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet 2006; 367: 225.
  • 3
    Varotti G, Grazi GL, Vetrone G, et al. Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-center experience. Clin Transplant 2005; 19: 492.
  • 4
    The US Multicenter FK506 Liver Study Group: a comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 1110.
  • 5
    European FK506 Multicentre Liver Study Group. Randomized trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 1994; 344: 423.
  • 6
    Neuhaus P, Blumhardt G, Bechstein WO, et al. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience. Transplantation 1995; 59: 31.
  • 7
    Adam R, McMaster P, O’Grady JG, et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 2003; 9: 1231.
  • 8
    Busuttil RW, Farmer DG, Yersiz H, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades. Ann Surg 2005; 241: 905.
  • 9
    Jain A, Reyes J, Kashyap R, et al. Long-term survival after liver transplantation in 4000 consecutive patients at a single center. Ann Surg 2000; 232: 490.
  • 10
    Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999; 19: 311.
  • 11
    Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693.
  • 12
    Molmenti EP, Klintmalm GB. Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry. Liver Transpl 2002; 8: 736.
  • 13
    Mueller AR, Platz KP, Kremer B. Early postoperative complications following liver transplantation. Best Pract Res Clin Gastroenterol. 2004; 18: 881.
  • 14
    Abbasoglu O, Levy MF, Brkic BB, et al. Ten years of liver transplantation: an evolving understanding of late graft loss. Transplantation 1995; 64: 1801.
  • 15
    Jain A, Reyes J, Kashyap R, et al. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1,000 patients Ann Surg 1999; 230: 441.
  • 16
    Salizzoni M, Cerutti E, Romagnoli R, et al. The first one thousand liver transplants in Turin: a single-center experience in Italy. Transpl Int 2005; 18: 1328.
  • 17
    Amador A, Charco R, Marti R, et al. One thousand liver transplants: the hospital clinic experience. Transplant Proc 2005; 37: 3916.
  • 18
    Bilbao I, Armadans L, Lazaro JL, Hidalgo E, Castells L, Margarit C. Predictive factors for early mortality following liver transplantation. Clin Transplant 2003; 17: 401.
  • 19
    Rayes N, Seehofer D, Theruvath T, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - a randomized, double-blind trial. Am J Transplant 2005; 5: 125.
  • 20
    Zwaveling JH, Maring JK, Klompmaker IJ, et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo-controlled trial in liver transplant patients. Crit Care Med 2002; 30: 1204.
  • 21
    Emre S, Sebastian A, Chodoff L, et al. Selective decontamination of the digestive tract helps prevent bacterial infections in the early postoperative period after liver transplant. Mt Sinai J Med 1999; 66: 310.
  • 22
    Rayes N, Seehofer D, Hansen S, et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 2002; 74: 123.
  • 23
    Echaniz A, Pita S, Otero A, Suarez F, Gomez M, Guerrero A. Incidence, risk factors and influence on survival of infectious complications after liver transplantation. Entferm Infec Micribiol Clin 2003; 21: 224.
  • 24
    Neuberger J. Incidence, timing, and risk factors for acute and cR. Review. Liver Transpl Surg 1999; 5: S30.
  • 25
    Cohen AJ, Stegall MD, Rosen CB, et al. Chronic renal dysfunction late after liver transplantation. Liver Transplant 2002; 8: 916.
  • 26
    Pawarode A, Fine DM, Thuluvath PJ. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transplant 2003; 9: 741.
  • 27
    Abbasoglu O, Levy MF, Vodapally MS, et al. Hepatic artery stenosis after liver transplantation – incidence, presentation, treatment, and long term outcome. Transplantation 1997; 63: 250.
  • 28
    Jain A, Costa G, Marsh W, et al. Thrombotic and nonthrombotic hepatic artery complications in adults and children following primary liver transplantation with long-term follow-up in 1000 consecutive patients. Transpl Int 2006; 19: 27.
  • 29
    Cavallari A, Vivarelli M, Belusci R, Jovine E, Mazziotti A, Rossi C. Treatment of vascular complications following liver transplantation: multidisciplinary approach. Hepatogastroenterology 2001; 48: 179.
  • 30
    Gunsar F, Rolando N, Pastacaldi S, et al. Late hepatic artery thrombosis after orthotopic liver transplantation. Liver Transpl 2003; 9: 605.
  • 31
    Settmacher U, Stange B, Haase R, et al. Arterial complications after liver transplantation. Transpl Int 2001; 13: 372.
  • 32
    Settmacher U, Nussler NC, Glanemann M, et al. Venous complications after orthotopic liver transplantation. Clin Transplant 2000; 14: 235.
  • 33
    Gopal DV, Pfau PR, Lucey MR. Endoscopic management of biliary complications after orthotopic liver transplantation. Curr Treat Gastroenterol 2003; 6: 509.
  • 34
    Moser MAJ, Wall WJ. Management of biliary problems after liver transplantation. Liver Transpl 2001; 7(Suppl. 1): S46.
  • 35
    Nemec P, Ondrasek J, Studenik P, Hokl J, Cerny J. Biliary complications in liver transplantation. Ann Transplant 2001; 6: 24.
  • 36
    Asfar S, Metrakos P, Fryer J, et al. An analysis of late deaths after liver transplantation. Transplantation 1996; 61: 1377.
  • 37
    Pruhti J, Medkiff KA, Esrason KT, et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transplant 2001; 7: 811.
  • 38
    Sheiner PA, Magliocca JF, Bodian CA, et al. Long-term medical complications in patients surviving = or >5 years after liver transplant. Transplantation 2000; 69: 781.
  • 39
    Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, Nussler NC. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2007; 13: 197.
  • 40
    Pascher A, Jonas S, Neuhaus P. Intrahepatic cholangiocarcinoma: indication for transplantation. J Hepatobiliary Pancreat Surg 2003; 10: 282.
  • 41
    Johnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002; 73: 901.
  • 42
    Duvoux C. De novo tumours after liver transplantation in adults. What is the actual risk? J Hepatol 2001; 34: 161.
  • 43
    Fung JF, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B. De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 2001; 7: S109.
  • 44
    Haagsma EB, Hagens VE, Schaapveld M, et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 2001; 34: 84.
  • 45
    Sanchez EQ, Marubashi S, Jung G, et al. De novo tumors after liver transplantation: a single-institution experience. Liver Transpl 2002; 8: 285.
  • 46
    Xiol X, Guardiola J, Menendez S, et al. Risk factors for development of de novo neoplasia after liver transplantation. Liver Transpl 2001; 7: 971.
  • 47
    Munoz SJ, Rothstein KD, Reich D, Manzarbeitia C. Long-term care of the liver transplant recipient. Clin Liver Dis 2000; 4: 691.
  • 48
    Manns MP, Neuhaus P, Atkinson GF, et al. Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-center study. Transpl Infect Dis 2001; 3: 16.
  • 49
    Dumortier J, Chevallier P, Scoazec JY, Berger F, Boillot O. Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results. Am J Transplant 2003; 3: 999.
  • 50
    Bienzle U, Günther M, Neuhaus R, et al. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. J Hepatol 2004; 38: 811.
  • 51
    Samuel D, Bizollon T, Feray C, et al. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology 2003; 124: 642.
  • 52
    Blumhardt G, Lemmens P, Topalidis T, et al. Increased flow rate of preservation solution in the hepatic artery during organ preservation can improve postiscemic liver function. Transplant Proc 1993; 25: 2540.
  • 53
    Neuhaus P, Blumhardt G, Bechstein WO, Steffen R, Platz K-P, Keck H. Technique and results of biliary reconstruction using side-to-side choledocho-choledochostomy in 300 orthotopic liver transplants. Ann Surg 1994; 219: 426.
  • 54
    Steinmüller T, Stockmann M, Bechstein WO, Settmacher U, Jonas S, Neuhaus P. Liver transplantation and diabetes mellitus. Exp Clin Endocrinol Diabetes 2000; 108: 401.
  • 55
    John PR, Thuluvath PJ. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl 2002; 8: 708.
  • 56
    Yoo HY, Thuluvath PJ. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation 2002; 74: 1007.
  • 57
    Baid S, Cosimi AB, Farrell ML, et al. Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001; 72: 1066.
  • 58
    Blanco JJ, Herrero JI, Quiroga J, et al. Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events. Liver Transpl 2001; 7: 226.
  • 59
    Textor SC, Taler SJ, Canzanello VJ, Schwartz L, Augustine JE. Posttransplantation hypertension related to calcineurin inhibitors. Liver Transplant 2000; 6: 521.
  • 60
    Reich D, Rothstein K, Manzarbeitia C, Munoz SJ. Common medical diseases after liver transplantation. Semin Gastrointest Dis 1998; 9: 110.
  • 61
    Keeffe BG, Valentine H, Keeffe EB. Detection and treatment of coronary artery disease in liver transplant candidates. Liver Transpl 2001; 7: 755.
  • 62
    Ghaus N, Bohlega S, Rezeig M. Neurological complications in liver transplantation. J Neurol 2001; 248: 1042.
  • 63
    Bronster DJ, Emre S, Boccagni P, Sheiner PA, Schwartz ME, Miller CM. Central nervous system complications in liver transplant recipients – incidence, timing, and long-term follow-up. Clin Transplant 2000; 14: 1.
  • 64
    Hay JE. Osteoporosis in liver diseases and after liver transplantation. J Hepatol 2003; 38: 856.
  • 65
    Barkmann A, Nashan B, Schmidt HHJ, et al. Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolatemofetil. Transplantation 2000; 69: 1886.
  • 66
    Pfitzmann R, Klupp J, Langrehr JM, et al. Mycophenolatmofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients. Transplantation 2003; 76: 130.